Healthpeak Properties (NYSE:DOC) Stock, Quote.Headers.trade-ideas

Healthpeak Properties

Physicians Realty Trust

Healthpeak owns a diversified healthcare portfolio of approximately 748 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.

Earnings

Earnings Beats

News

REIT

Guidance

Markets

Analyst Ratings

Trading Ideas

Real Estate

SBAC

SBA Communications Corporation (NASDAQ: SBAC) reported second-quarter 2024 adjusted funds from operations (AFFO) per share of $3.29, beating the Zacks Consensus Estimate by a whisker. Moreover, the figure reflects a rise of 1.5% from the prior-year quarter.

SBA Communications&#39; Q2 AFFO Beat, Revenues Fall Y/Y

AGNC

Wall Street watches a company&#39;s quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among the rest: earnings.

These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar

Miniature,Wooden,Houses,And,A,Green,Arrow,Down.,The,Concept

7 REITs Receive Analyst Upgrades In The First Week Of May

Healthpeak Properties Inc

Dock - United States Dollar

BEYOND MED TECHS INC by BEYOND MED TECHNOLOGIES INC.

Beyond Medical Technologies Inc

Dr. Martens PLC

DigitalOcean Holdings Inc

Docola, Inc

CloudMD Software & Services Inc Ordinary Shares

Doximity Inc

FT Vest U.S. Equity Deep Buffer ETF - October

LG HEALTHCARE BREAKTHROUGH UCITS ETF

DocuSign Inc

Scotiabank analyst Nicholas Yulico maintains Healthpeak Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) with a Sector Outperform and raises the price target from $23 to $24.

Price Target

Scotiabank Maintains Sector Outperform on Healthpeak Properties, Raises Price Target to $24

Healthpeak Properties's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) short percent of float has risen 36.3% since its last report. The company recently reported that it has 11.00 million shares sold short, which is 1.99% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.61 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Healthpeak Properties Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725542116_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Healthpeak Properties has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Healthpeak Properties's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Healthpeak Properties's peer group average for short interest as a percentage of float is 6.65%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Healthpeak Properties's Recent Short Interest

In the latest quarter, 4 analysts provided ratings for Healthpeak Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $24.25, along with a high estimate of $25.00 and a low estimate of $22.00. Marking an increase of 10.23%, the current average surpasses the previous average price target of $22.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1724864475_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A clear picture of Healthpeak Properties's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Kammert</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$25.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Michael Bilerman</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Michael Carroll</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$25.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$25.00</td>
<td>$22.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Healthpeak Properties. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Healthpeak Properties compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Healthpeak Properties's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Healthpeak Properties's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/DOC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Healthpeak Properties analyst ratings.</a>
<h2>About Healthpeak Properties</h2>
Healthpeak owns a diversified healthcare portfolio of approximately 748 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.
<h3>Healthpeak Properties's Economic Impact: An Analysis</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Healthpeak Properties's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 27.31%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: Healthpeak Properties's net margin is impressive, surpassing industry averages. With a net margin of 21.21%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Healthpeak Properties's ROE excels beyond industry benchmarks, reaching 1.65%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Healthpeak Properties's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.72% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a below-average debt-to-equity ratio of 1.02, Healthpeak Properties adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Scoreboard: 4 Ratings For Healthpeak Properties

Evercore ISI Group analyst James Kammert maintains Healthpeak Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) with a Outperform and raises the price target from $24 to $25.

Evercore ISI Group Maintains Outperform on Healthpeak Properties, Raises Price Target to $25

Citigroup analyst Michael Bilerman maintains Healthpeak Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) with a Neutral and raises the price target from $20 to $22.

Citigroup Maintains Neutral on Healthpeak Properties, Raises Price Target to $22

Healthpeak Properties's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) short percent of float has fallen 4.32% since its last report. The company recently reported that it has 9.83 million shares sold short, which is 1.77% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.61 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Healthpeak Properties Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1723230915_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Healthpeak Properties has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Healthpeak Properties's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Healthpeak Properties's peer group average for short interest as a percentage of float is 6.97%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Healthpeak Properties?

4 analysts have shared their evaluations of Healthpeak Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $23.5, with a high estimate of $25.00 and a low estimate of $21.00. This upward trend is evident, with the current average reflecting a 10.59% increase from the previous average price target of $21.25.
<img src="https://www.benzinga.com/files/images/story/2024/1722344472_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Healthpeak Properties among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Carroll</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$25.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$25.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$23.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Michael Mueller</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$21.00</td>
<td>$19.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Healthpeak Properties. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Healthpeak Properties compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Healthpeak Properties's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Healthpeak Properties's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DOC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Healthpeak Properties analyst ratings.</a>
<h2>Delving into Healthpeak Properties's Background</h2>
Healthpeak owns a diversified healthcare portfolio of approximately 748 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.
<h3>Financial Milestones: Healthpeak Properties's Journey</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Over the 3 months period, Healthpeak Properties showcased positive performance, achieving a revenue growth rate of 27.31% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Real Estate sector.
Net Margin: Healthpeak Properties's net margin excels beyond industry benchmarks, reaching 21.21%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Healthpeak Properties's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 1.65%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Healthpeak Properties's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.72% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a below-average debt-to-equity ratio of 1.02, Healthpeak Properties adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Basics of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

In-Depth Examination Of 4 Analyst Recommendations For Healthpeak Properties

RBC Capital analyst Michael Carroll maintains Healthpeak Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) with a Outperform and raises the price target from $22 to $25.

RBC Capital Maintains Outperform on Healthpeak Properties, Raises Price Target to $25

Wedbush analyst Richard Anderson maintains Healthpeak Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) with a Outperform and raises the price target from $22 to $25.

Wedbush Maintains Outperform on Healthpeak Properties, Raises Price Target to $25

WIIM

Healthpeak properties shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 earnings guidance.

2024 GUIDANCE
We are updating the following guidance ranges for full year 2024:
<ul>
<li>Diluted earnings per common share from $0.16 – $0.20 to $0.27 – $0.31</li>
<li>Diluted Nareit FFO per share from $1.56 – $1.60 to $1.59 – $1.63</li>
<li>Diluted FFO as Adjusted per share from $1.76 – $1.80 to $1.77 – $1.81</li>
<li>Diluted AFFO per share from $1.53 – $1.57 to $1.54 – $1.58</li>
<li>Total Merger-Combined Same-Store Cash (Adjusted) NOI growth from 2.50% – 4.00% to 2.75% – 4.25%</li>
</ul>

Healthpeak Properties Increased FY24 Diluted Earnings Guidance From $0.16-$0.20 To $0.27–$0.31 Per Share; Increased The Midpoint Of Each 2024 FFO As Adjusted And AFFO Guidance By +$0.01 Per Share

Healthpeak Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.44 by 2.27 percent. This is a 80 percent increase over earnings of $0.25 per share from the same period last year. The company reported quarterly sales of $695.50 million which beat the analyst consensus estimate of $660.55 million by 5.29 percent. This is a 27.51 percent increase over sales of $545.43 million the same period last year.

Healthpeak Properties Q2 FFO $0.45 Beats $0.44 Estimate, Sales $695.50M Beat $660.55M Estimate

Healthpeak Properties's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) short percent of float has fallen 11.06% since its last report. The company recently reported that it has 10.30 million shares sold short, which is 1.85% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.84 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Healthpeak Properties Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721847622_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Healthpeak Properties has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Healthpeak Properties's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Healthpeak Properties's peer group average for short interest as a percentage of float is 6.53%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into Healthpeak Properties's Recent Short Interest

Healthpeak Properties's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) short percent of float has fallen 3.7% since its last report. The company recently reported that it has 11.55 million shares sold short, which is 2.08% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.37 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Healthpeak Properties Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1719930611_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Healthpeak Properties has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Healthpeak Properties's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Healthpeak Properties's peer group average for short interest as a percentage of float is 6.76%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Analysts' ratings for Healthpeak Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) over the last quarter vary from bullish to bearish, as provided by 7 analysts.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Healthpeak Properties and provided 12-month price targets. The average target is $21.86, accompanied by a high estimate of $25.00 and a low estimate of $19.00. Witnessing a positive shift, the current average has risen by 9.3% from the previous average price target of $20.00.
<img src="https://www.benzinga.com/files/images/story/2024/1715868023_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Healthpeak Properties. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$23.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Michael Mueller</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$21.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Vikram Malhotra</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Buy</td>
<td>$22.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Carroll</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$22.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Joshua Dennerlein</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$25.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Connor Siversky</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$19.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Carroll</td>
<td>RBC Capital</td>
<td>Announces</td>
<td>Outperform</td>
<td>$21.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Healthpeak Properties. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Healthpeak Properties compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Healthpeak Properties's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Healthpeak Properties's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/DOC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Healthpeak Properties analyst ratings.</a>
<h2>About Healthpeak Properties</h2>
Healthpeak owns a diversified healthcare portfolio of approximately 459 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.
<h3>Healthpeak Properties's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Over the 3 months period, Healthpeak Properties showcased positive performance, achieving a revenue growth rate of 15.65% as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Real Estate sector.
Net Margin: Healthpeak Properties's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 1.08%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Healthpeak Properties's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.08%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Healthpeak Properties's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.04%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 1.02, Healthpeak Properties adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cracking The Code: Understanding Analyst Reviews For Healthpeak Properties

Scotiabank analyst Nicholas Yulico maintains Healthpeak Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) with a Sector Outperform and raises the price target from $22 to $23.

Scotiabank Maintains Sector Outperform on Healthpeak Properties, Raises Price Target to $23

JP Morgan analyst Michael Mueller maintains Healthpeak Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) with a Neutral and raises the price target from $19 to $21.

JP Morgan Maintains Neutral on Healthpeak Properties, Raises Price Target to $21

Analyst upgrades are always welcome news for investors because upgrades trigger buying activity which supports share price appreciation.
It looks like Analysts are feeling better about the future direction of interest rates and interest-sensitive stocks such as real estate investment trusts (REITs) because, this week, seven different REITs across five different subsectors have received analyst upgrades.
Sunstone Hotel Investors Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHO#NYSE">SHO</a>) is an Aliso Viejo, CA-based Hotel REIT with 6675 rooms in 14 hotels, on both U.S. coasts and Hawaii. Its hotel brands include Hyatt Regency, Marriott, Hilton, and Four Seasons.
On May 8, Sunstone Hotel Investors reported its first quarter 2024 operating results. Funds from Operation (FFO) of $0.19 per share beat the estimate of $0.17 per share but was below $0.21 per share FFO in Q1 2023. Revenue of $217.166 million was ahead of the estimate of $214.595 million but below revenue of $243.443 million in Q1 2023.
Disregarding the decreases from the year-ago period, On May 7, Compass Point analyst Floris Van Dijkum upgraded Sunstone Hotel from Sell to Neutral and raised the price target from $10 to $12.
Don't Miss:
<ul>
<li>Only 0.2% of single-family rentals make this platform's rigorous cut. You can co-invest in them <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">with Jeff Bezos and other notable investors for only $100</a>.</li>
<li>New York is the second financial capital in the US' history. Now a third one is emerging and <a href="https://www.benzinga.com/money/cityfunds-yield">investing in its booming real estate market</a> takes as little as $500 and a few clicks. </li>
</ul>
Camden Property Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPT#NYSE">CPT</a>) is a Houston, TX-based residential REIT that owns and manages 172 properties with 58,634 units in 15 major cities across the U.S. Some apartment complexes also contain ground-floor retail space, offices, or mixed-use space. It's a member of the Standard &amp; Poor&#8217;s 500 index (S&amp;P 500 and) and had its IPO in 1993. At the end of Q3 2023, its occupancy level was 95.0%.
On May 6, Piper Sandler analyst Alexander Goldfarb upgraded Camden Property Trust from Underweight to Neutral and raised the price target from $90 to $110. Three other Brokerages maintained previous positions on the same day, with all raising price targets between $110 and $118.
Mid-America Apartment Communities Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAA#NYSE">MAA</a>) is a self-administered residential REIT specializing in purchasing and leasing apartment complexes. As of March 2024, it owns 102,662 units in 300 communities across 16 states and Washington, D.C. Most Mid-America Apartment Communities' properties are in the Southeast, Southwest, and mid-Atlantic states.
On May 1, Mid-America reported its Q1 2024 operating results. FFO of $2.22 was in line with estimates but was below FFO of $2.28 from Q1 2023. Revenue of $543.62 million beat the estimate of $542.72 million and was above Q1 2023 revenue of $529.03 million.
On May 6, Wedbush analyst Richard Anderson upgraded Mid-America Apartment from Neutral to Outperform, raising the price target by 14% from $135 to $154.&nbsp;
&nbsp;Trending:
<ul>
<li>Elon Musk, Ken Griffin and Jeff Bezos are bullish on one city that could dethrone New York and become the new financial capital of the US. <a href="https://www.benzinga.com/money/cityfunds-yield">Investing in its booming real estate market has never been more accessible</a>. </li>
</ul>
Healthpeak Properties Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) is an El Segundo, CA-based diversified health care REIT that owns and operates private-pay facilities such as life science centers, medical offices, and continuing care retirement communities. Although it has properties throughout the country, most are in the San Francisco, San Diego, and Boston areas. Healthpeak's IPO was created in 1985 and was added to the S&amp;P 500 in 2008. It presently owns 774 properties worth over $20 billion.
On March 1, Healthpeak officially merged with Physicians Realty Trust in an all-stock-for-stock transaction.&nbsp;
On April 25, Healthpeak reported its first quarter 2024 operating results. FFO of $0.45 per share was a penny above the consensus estimate and a 7.14% increase over FFO of $0.42 per share in Q1 2023. Revenue of $606.560 million topped the consensus estimate of $588.284 million and was a 15.39% increase over revenue of $525.678 million in Q1 2023.
Healthpeak also announced an increase in its FY24 Diluted Adjusted Funds From Operations (AFFO) Guidance from $1.50-$1.56 to $1.53-$1.57.&nbsp;
Investors cheered the news and Healthpeak rose over 2% following its earnings and guidance release.
On May 3, Wedbush analyst Richard Anderson upgraded Healthpeak Properties from Neutral to Outperform. No price target was given.
Tanger Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKT#NYSE">SKT</a>), formerly called Tanger Factory Outlet Centers Inc, is a Greensboro, NC-based retail REIT that owns, co-owns, or manages 40 indoor shopping centers and outdoor factory outlet malls with 15.6 million square feet and over 3000 stores across 20 states and in Canada. Tanger Factory Outlet Centers was founded in 1981 and had its IPO in May 1993. Tanger's occupancy rate at the end of 2023 was 97.3%
On April 30, Tanger reported excellent first quarter operating results. FFO of $0.52 beat the estimate of $0.51 and topped its Q1 2023 FFO of $0.46 per share. Revenue of $123.371 million beat the estimate of $122.804 million and was 13.24% above revenue from Q4 2022 of $108.943 million. Tanger also raised its Full Year 2024 Core FFO from $2.01-$2.09 per share to $2.03-$2.11.&nbsp;
On May 2, Compass Point analyst Floris Van Dijkum upgraded Tanger from Neutral to Buy and announced a price target of $32.
PotlatchDeltic Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCH#NASDAQ">PCH</a>) is a specialty REIT that invests in timberland. The Spokane, WA-based company owns nearly 2.2 million acres of timberlands across seven states. It was founded in the year 1903 as Clearwater Timber Company and became a REIT in 2006. PotlatchDeltic merged with CatchMark Timer Trust, Inc. in 2022.
On April 29, PotlatchDeltic released its first quarter 2024 operating results. Non-GAAP EPS of $0.00 beat the estimates of (0.02). Revenue of $228.127 million was ahead of the consensus estimate of $227.841 million and was 11.57% below its Q1 2023 revenue of $257.962 million.
On May 1, RBC Capital analyst Matthew McKellar upgraded PotlatchDeltic from Sector Perform to Outperform and announced a $46 price target.
American Tower Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMT#NYSE">AMT</a>) is a Boston, MA-based specialty REIT that calls itself "a global leader in wireless infrastructure." Founded in 1995, American Tower owns, operates, and develops wireless and broadcast communications real estate. Most of its business is leasing space on wireless and broadcast towers and it also leases portions of the land below the tower for equipment storage. Typical tower components are coaxial cabling and fiber optic cables.
American Tower has a presence in 224,000 global communication sites across 25 different countries in six continents. About 42,000 of those properties are in the U.S. and Canada, and approximately 181,000 are international properties
On April 30, American Tower released its first quarter 2024 operating results. Adjusted Funds from Operations (AFFO) of $2.79 per share easily beat the consensus estimate of $2.54 per share, and AFFO of $2.54 in Q1 2023. Revenue of $2.834 billion also beat the street's view of $2.795 billion and topped revenue of $2.767 billion from Q1 2023.
On May 1, Raymond James analyst Ric Prentiss upgraded American Tower from Outperform to Strong Buy and raised the price target from $226 to $248.
Read Next:
<ul>
<li>Want to Create a Passive Income Stream? <a href="https://www.benzinga.com/real-estate/23/05/32554601/want-to-grow-your-wealth-passively-these-high-yield-real-estate-notes-might-be-your-holy-grail">These High-Yield Real Estate Notes Might Be Your Holy Grail</a></li>
<li>Dara Khosrowshahi-Backed Startup Lets You <a href="https://www.benzinga.com/money/dara-khosrowshahi-backed-startup-lets-you-become-a-landlord-with-100">Become a Landlord with $100</a>.</li>
</ul>

Healthpeak Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) ("Healthpeak") and King Street Properties ("KSP") today announced that Healthpeak has acquired KSP's minority interest in the joint ventures in eight lab buildings in Cambridge and Lexington, Massachusetts. Healthpeak will assume day-to-day management of the buildings following a short-term transition period.
"King Street has been a key strategic partner of Healthpeak's since 2017," said Scott Brinker, Healthpeak's President and CEO. "Our successful partnership grew to 900,000 square feet across four campuses." Mr. Brinker continued, "Healthpeak's greater Boston portfolio now totals 2.7 million square feet, giving us the scale to internalize. We would like to thank the KSP team for many years of outstanding partnership and mutual success."
"Seven years ago, we and Healthpeak formed a joint venture to maximize the development potential of a portion of King Street's Boston portfolio of Class A life science projects," said Thomas Ragno, King Street's Founder/Principal. "We enjoyed working with the Healthpeak team to meet that goal and today marks the culmination of this innovative approach, which has proven to be highly successful for both firms."

Healthpeak Properties Has Acquired KSP's Minority Interest In The Joint Ventures In Eight Lab Buildings In Cambridge And Lexington, Massachusetts; No Financial Terms Disclosed

Wedbush analyst Richard Anderson upgrades Healthpeak Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) from Neutral to Outperform.

Upgrades

Wedbush Upgrades Healthpeak Properties to Outperform

Baron Real Estate Income Fund Q2 2024 Shareholder Letter

Real stocks eke out gains as the sector gears up for changes

Wells Fargo analyst James Feldman maintained a Hold rating on Healthpeak Properties (DOC – Research Report) today and set a price target of $22.00....

Healthpeak Properties (DOC) Gets a Hold from Wells Fargo

Rate-sensitive real estate stocks outperform broader markets

Healthpeak Properties (DOC – Research Report), the Real Estate sector company, was revisited by a Wall Street analyst today. Analyst Ronald Kamdem ...

Healthpeak Properties Hold Rating: Balancing Merger Benefits Against Lab Space Market Risks

Real estate stocks surge in August, set to rebound after underperformance

If I Had To Retire Today With 10 REITs - Part 2

Jane's July 2024 Retirement Income Update: Lamb Weston Smackdown

Real estate stocks start one of the worst months for equities on a strong note

Scotiabank analyst Nicholas Yulico maintained a Buy rating on Healthpeak Properties (DOC – Research Report) today and set a price target of $24.00....

Scotiabank Reaffirms Their Buy Rating on Healthpeak Properties (DOC)

ALBT

BBRE

BCAP

BROE

BTAFF

CBRE

CSGP

DFAR

EQIX

FREL

INDS

INVH

JPRE

KBWY

MAIN

MORT

NETL

NURE

PPTY

REXR

RIET

ROOF

RSPR

SCHH

SPRE

SRET

SRVR

TRNO

UNLYF

USRT

VICI

WELL

WETH

WHLR

XLRE

Press Releases

Healthpeak Properties, Inc. and Healthpeak OP, LLC Complete Consent Solicitation and Offers to Guarantee and Receive Required Consents to Amend Physicians Realty L.P. Indentures

American Homes 4 Rent Set to Join S&P MidCap 400

Healthpeak Properties Announces First Quarter 2024 Earnings Release Date and Conference Call Details

Healthpeak Properties Reports First Quarter 2024 Results and Declares Quarterly Cash Dividend on Common Stock

Legal

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Physicians Realty Trust and Encourages Investors to Contact the Firm

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Healthpeak Properties

Healthpeak Properties (DOC) Forecast

Healthpeak Properties (NYSE:DOC) Stock, Quote.Headers.trade-ideas